74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Jazz Pharmaceuticals PLC
Closed
SectorHealthcare
108.96 4.61
Overview
Share price change
24h
Min
102.82
Max
109.06
Income | -24M 191M |
|---|---|
Sales | 33M 1.1B |
P/E Sector Avg | 11.6 57.333 |
EPS | 6.6 |
Profit margin | 17.563 |
Employees | 2,800 |
EBITDA | -234M 191M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +80.71% upside |
Next Earnings | 6 May 2025 |
|---|
Market Cap | -2.2B 6.1B |
|---|---|
Previous open | 104.35 |
Previous close | 108.96 |
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Jazz Pharmaceuticals PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Jazz Pharmaceuticals PLC Forecast
Price Target
By TipRanks
80.71% upside
12 Months Forecast
Average 186.82 USD 80.71%
High 230 USD
Low 100 USD
Based on 18 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
